|
|
Post by rockstarrick on Apr 26, 2015 10:00:04 GMT -5
|
|
|
|
Post by rockstarrick on Apr 26, 2015 10:12:33 GMT -5
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company that is engaged in the development, manufacture and marketing of generic and proprietary injectable and inhalation products. Amphastar and its subsidiaries are all recognized names in the pharmaceutical industry whose capabilities have evolved over the years. Although each unit has its own distinct focus, each compliments the others. Together they strive to meet the varied needs of the pharmaceutical industry.
|
|
|
|
Post by rockstarrick on Apr 26, 2015 10:14:05 GMT -5
I wonder why we chose Amphastar ?? For insulin only,......... I don't think so.
|
|
|
|
Post by rockstarrick on Apr 26, 2015 10:21:20 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 26, 2015 10:51:02 GMT -5
I wonder why we chose Amphastar ?? For insulin only,......... I don't think so. MNKD didn't have a "choice". It was (and still is) the only FDA approved insulin. |
|
|
|
Post by rockstarrick on Apr 26, 2015 10:59:28 GMT -5
Maybe the generic factor is a bonus. This topic was brought up by Lakers on YMB, but didn't get a lot of discussion. I think he may be on to something. Just sharing.
Thanks
|
|
|
|
Post by kpm1028 on Apr 26, 2015 11:52:36 GMT -5
I wonder why we chose Amphastar ?? For insulin only,......... I don't think so. MNKD didn't have a "choice". It was (and still is) the only FDA approved insulin. How is it possible a small company like amph have a monopoly the entire recombinant insulin, did they also receive the rights to the process to make it when they bought the facility that produces it? I have owned amph since they said that they would instantly become profitable from the mnkd deal, and that was when they were in the $9 range. I would love to see their relationship grow in the future to possibly mnkd licensing them techno for more products |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 26, 2015 11:58:06 GMT -5
How is what possible? They own the only facility that manufactures insulin that is approved by the FDA for use in afrezza. It's that simple.
|
|
|
|
Post by rockstarrick on Apr 26, 2015 12:18:57 GMT -5
MNKD didn't have a "choice". It was (and still is) the only FDA approved insulin. How is it possible a small company like amph have a monopoly the entire recombinant insulin, did they also receive the rights to the process to make it when they bought the facility that produces it? I have owned amph since they said that they would instantly become profitable from the mnkd deal, and that was when they were in the $9 range. I would love to see their relationship grow in the future to possibly mnkd licensing them techno for more products Inhaled Generics, seems logical to me |
|
|
|
Post by fpants on Apr 26, 2015 15:40:12 GMT -5
I have no links for you but it's my understanding that Sanofi owns the insulin plant in Germany used for Exubera and the intention is to switch to that from Amph eventually, contract extension with amph notwithstanding.
|
|
